Pharmacological rationale for antihypertensive drug choice on COVID-19-affected patients: ACEI/ARB might not increase their susceptibility

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Pharmacological rationale for antihypertensive drug choice on COVID-19-affected patients: ACEI/ARB might not increase their susceptibility

Abstract

References

Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors

Severe acute respiratory syndrome, Beijing, 2003

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

Age- and gender-related difference of ACE2 expression in rat lung

Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome

Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice

The "his and hers" of the renin-angiotensin system

Burden of hypertension in China: A nationally representative survey of 174,621 adults

Blood pressure and the new ACC/AHA hypertension guidelines

A new coronavirus associated with human respiratory disease in China.

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Clinical Characteristics of Coronavirus Disease 2019 in China.

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19

The Association Between the Rate of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Use and the Number of Covid-19 Confirmed Cases and Deaths in the United States: Geospatial Study.

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Related Papers

Morphology of COVID-19-affected cells in peripheral blood film

Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension

COVID-19 and ACEI/ARB: Not Associated?

Response to "COVID-19 and ACEI/ARB: Not Associated?"

Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers (ACEI/ARB) are Associated with Improved Limb Salvage after Infrapopliteal Interventions for Critical Limb Ischemia